Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.

Morgan DJ, Day HR, Furuno JP, Young A, Johnson JK, Bradham DD, Perencevich EN.

Infect Control Hosp Epidemiol. 2010 Dec;31(12):1230-5. doi: 10.1086/657335. Epub 2010 Oct 28.

2.

Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.

Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, Furuno JP.

Infect Control Hosp Epidemiol. 2011 May;32(5):481-9. doi: 10.1086/659403. Review.

3.

Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare.

Calfee DP.

Curr Opin Infect Dis. 2012 Aug;25(4):385-94. doi: 10.1097/QCO.0b013e3283553441. Review.

PMID:
22614523
4.
5.

Vancomycin-resistant enterococci: consequences for therapy and infection control.

Mascini EM, Bonten MJ.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:43-56. Review.

6.

Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.

Shenoy ES, Paras ML, Noubary F, Walensky RP, Hooper DC.

BMC Infect Dis. 2014 Mar 31;14:177. doi: 10.1186/1471-2334-14-177. Review.

7.

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM; SHEA.

Infect Control Hosp Epidemiol. 2003 May;24(5):362-86. Review.

PMID:
12785411
8.

[Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].

Cantón R, Ruiz-Garbajosa P.

Enferm Infecc Microbiol Clin. 2013 Oct;31(8):543-51. doi: 10.1016/j.eimc.2013.08.001. Epub 2013 Sep 14. Review. Spanish.

PMID:
24041416
9.
11.

Vancomycin-resistant enterococci.

Cetinkaya Y, Falk P, Mayhall CG.

Clin Microbiol Rev. 2000 Oct;13(4):686-707. Review.

12.

[Multiresistant gram-negative bacteria. A bacterial challenge of the twenty-first century].

Schröppel K, Riessen R.

Med Klin Intensivmed Notfmed. 2013 Mar;108(2):107-12. doi: 10.1007/s00063-012-0160-8. Epub 2013 Mar 13. Review. German.

PMID:
23479223
13.

[Development of antimicrobial resistance in Germany : What is the current situation?]

Maechler F, Geffers C, Schwab F, Peña Diaz LA, Behnke M, Gastmeier P.

Med Klin Intensivmed Notfmed. 2017 Apr;112(3):186-191. doi: 10.1007/s00063-017-0272-2. Epub 2017 Apr 4. Review. German.

PMID:
28378152
14.

Treatment of Gram-positive infections in critically ill patients.

Vazquez-Guillamet C, Kollef MH.

BMC Infect Dis. 2014 Nov 28;14:92. doi: 10.1186/1471-2334-14-92. Review.

15.

Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Johnston BL, Bryce E.

CMAJ. 2009 Mar 17;180(6):627-31. doi: 10.1503/cmaj.080195. Review. No abstract available.

16.

[Rational antibiotic treatment of mediastinitis].

Ambrosch A.

Chirurg. 2016 Jun;87(6):497-503. doi: 10.1007/s00104-016-0192-3. Review. German.

PMID:
27193005
17.

Risk factors for the spread of antibiotic-resistant bacteria.

Rao GG.

Drugs. 1998 Mar;55(3):323-30. Review.

PMID:
9530540
18.

Antibiotic resistance. Control strategies.

Cunha BA.

Crit Care Clin. 1998 Apr;14(2):309-27. Review.

PMID:
9561819
19.

Novel anti-infective compounds from marine bacteria.

Rahman H, Austin B, Mitchell WJ, Morris PC, Jamieson DJ, Adams DR, Spragg AM, Schweizer M.

Mar Drugs. 2010 Mar 5;8(3):498-518. doi: 10.3390/md8030498. Review.

20.

Control of antibiotic-resistant bacteria in the office and clinic.

Matlow AG, Morris SK.

CMAJ. 2009 May 12;180(10):1021-4. doi: 10.1503/cmaj.071891. Review. No abstract available.

Supplemental Content

Support Center